Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease

References

• Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–1986. doi: 10.1097/hep.0000000000000520.
   Web of Science ®Google Scholar
• Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (Nash): a systematic review. Hepatology. 2023;77(4):1335–1347. doi: 10.1097/hep.0000000000000004.
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119–1133. doi: 10.1002/hep.30702.
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896–904. doi: 10.1016/j.jhep.2018.05.036.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Haczeyni F, Chitturi S. Pathogenesis of nash: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv Exp Med Biol. 2018;1061:19–44. doi: 10.1007/978-981-10-8684-7_3.
   PubMed Web of Science ®Google Scholar
• Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun. 2020;4(4):478–492. doi: 10.1002/hep4.1479.
   PubMed Web of Science ®Google Scholar
• Geng Y, Faber KN, De Meijer VE, et al. How does hepatic lipid accumulation lead to lipotoxicity in non-Alcoholic fatty liver disease? Hepatol Int. 2021;15(1):21–35. doi: 10.1007/s12072-020-10121-2.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi: 10.1002/hep.28431.
   PubMed Web of Science ®Google Scholar
• Henry L, Paik J, Younossi ZM. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Aliment Pharmacol Ther. 2022;56(6):942–956. doi: 10.1111/apt.17158.
   PubMed Web of Science ®Google Scholar
• Varderidou-Minasian S, Lorenowicz MJ. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities. Theranostics. 2020;10(13):5979–5997. doi: 10.7150/thno.40122.
   PubMed Web of Science ®Google Scholar
• Han C, Yang J, Sun J, et al. Extracellular vesicles in cardiovascular disease: biological functions and therapeutic implications. Pharmacol Ther. 2022;233:108025. doi: 10.1016/j.pharmthera.2021.108025.
   PubMed Web of Science ®Google Scholar
• Newman LA, Muller K, Rowland A. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cell Mol Life Sci. 2022;79(5):232. doi: 10.1007/s00018-022-04256-8.
   Web of Science ®Google Scholar
• Kalluri R, Lebleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi: 10.1126/science.aau6977.
   PubMed Web of Science ®Google Scholar
• Dilsiz N. Hallmarks of exosomes. Future Sci OA. 2021;8(1):FSO764. doi: 10.2144/fsoa-2021-0102.
   Web of Science ®Google Scholar
• Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852. doi: 10.3390/ijms18091852.
   PubMed Web of Science ®Google Scholar
• Chen B, Cai J, Wei Y, et al. Exosomes are comparable to source adipose stem cells in fat graft retention with up-regulating early inflammation and angiogenesis. Plast Reconstr Surg. 2019;144(5):816e–827e. doi: 10.1097/PRS.0000000000006175.
   PubMed Web of Science ®Google Scholar
• Ghiasloo M, De Wilde L, Singh K, et al. A systematic review on extracellular vesicles-enriched fat grafting: a shifting paradigm. Aesthet Surg J. 2021;41(11):NP1695–NP1705. doi: 10.1093/asj/sjaa362.
   Web of Science ®Google Scholar
• Cocozza F, Grisard E, Martin-Jaular L, et al. Snapshot: extracellular vesicles. Cell. 2020;182(1):262–262.e261. doi: 10.1016/j.cell.2020.04.054.
   PubMed Web of Science ®Google Scholar
• Eitan E, Suire C, Zhang S, et al. Impact of lysosome status on extracellular vesicle content and release. Ageing Res Rev. 2016;32:65–74. doi: 10.1016/j.arr.2016.05.001.
   PubMed Web of Science ®Google Scholar
• Szatanek R, Baj-Krzyworzeka M, Zimoch J, et al. The methods of choice for extracellular vesicles (evs) characterization. Int J Mol Sci. 2017;18(6):1153. doi: 10.3390/ijms18061153.
   PubMed Web of Science ®Google Scholar
• Sidhom K, Obi PO, Saleem A. A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci. 2020;21(18):6466. doi: 10.3390/ijms21186466.
   PubMed Web of Science ®Google Scholar
• Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–455. doi: 10.1038/nature21365.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shang Q, Pan Z, et al. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes. 2018;67(2):235–247. doi: 10.2337/db17-0356.
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. doi: 10.1126/science.1064921.
   PubMed Web of Science ®Google Scholar
• Lau NC, Lim LP, Weinstein EG, et al. An abundant class of tiny RNAs with probable regulatory roles in caenorhabditis elegans. Science. 2001;294(5543):858–862. doi: 10.1126/science.1065062.
   PubMed Web of Science ®Google Scholar
• Berezikov E, Guryev V, Van De Belt J, et al. Phylogenetic shadowing and computational identification of human microrna genes. Cell. 2005;120(1):21–24. doi: 10.1016/j.cell.2004.12.031.
   PubMed Web of Science ®Google Scholar
• Mahmoudi A, Butler AE, Jamialahmadi T, et al. The role of exosomal miRNA in nonalcoholic fatty liver disease. J Cellular Physiol. 2022;237(4):2078–2094. doi: 10.1002/jcp.30699.
   PubMed Web of Science ®Google Scholar
• Broermann A, Schmid R, Gabrielyan O, et al. Exosomal miRNAs as potential biomarkers to monitor phosphodiesterase 5 inhibitor ­induced anti-fibrotic effects on Ccl4 treated rats. Int J Mol Sci. 2020;22(1):382. doi: 10.3390/ijms22010382.
   Web of Science ®Google Scholar
• Hu J, Jiang Y, Wu X, et al. Exosomal mir-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing Txnip-Nlrp3 inflammasome. Stem Cell Res Ther. 2022;13(1):349. doi: 10.1186/s13287-022-03037-1.
   Web of Science ®Google Scholar
• Martínez MC, Andriantsitohaina R. Extracellular vesicles in metabolic syndrome. Circ Res. 2017;120(10):1674–1686. doi: 10.1161/circresaha.117.309419.
   PubMed Web of Science ®Google Scholar
• Kariba Y, Yoshizawa T, Sato Y, et al. Brown adipocyte-derived exosomal mir-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes. Biochem Biophys Res Commun. 2020;530(3):500–507. doi: 10.1016/j.bbrc.2020.05.090.
   PubMed Web of Science ®Google Scholar
• Jung YJ, Kim HK, Cho Y, et al. Cell reprogramming using extracellular vesicles from differentiating stem cells into white/beige adipocytes. Sci Adv. 2020;6(13):eaay6721. doi: 10.1126/sciadv.aay6721.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tsuchiya A, Takeuchi S, et al. Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles. Regen Ther. 2020;14:252–261. doi: 10.1016/j.reth.2020.03.012.
   PubMed Web of Science ®Google Scholar
• Mahmood A, Seetharaman R, Kshatriya P, et al. Stem cell transplant for advanced stage liver disorders: current scenario and future prospects. CMC. 2020;27(37):6276–6293. doi: 10.2174/0929867326666191004161802.
   Google Scholar
• Mathieu M, Martin-Jaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9–17. doi: 10.1038/s41556-018-0250-9.
   PubMed Web of Science ®Google Scholar
• Couch Y, Buzas EI, Di Vizio D, et al. A brief history of nearly Ev-Erything - the rise and rise of extracellular vesicles. J Extracell Vesicles. 2021;10(14):e12144. doi: 10.1002/jev2.12144.
   PubMed Web of Science ®Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579. doi: 10.1038/nri855.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao Y, Yin Y, et al. Mechanism of cargo sorting into small extracellular vesicles. Bioengineered. 2021;12(1):8186–8201. doi: 10.1080/21655979.2021.1977767.
   PubMed Web of Science ®Google Scholar
• Brennan K, Martin K, Fitzgerald SP, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep. 2020;10(1):1039. doi: 10.1038/s41598-020-57497-7.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Di Vizio D, Sahoo S, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5(1):32945. doi: 10.3402/jev.v5.32945.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (Misev2018): a position statement of the international society for extracellular vesicles and update of the Misev2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi: 10.1080/20013078.2018.1535750.
   PubMed Web of Science ®Google Scholar
• Royo F, Théry C, Falcón-Pérez JM, et al. Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the isev rigor and standardization subcommittee. Cells. 2020;9(9):1955. doi: 10.3390/cells9091955.
   PubMed Web of Science ®Google Scholar
• Wang JM, Li YJ, Wu JY, et al. Comparative evaluation of methods for isolating small extracellular vesicles derived from pancreatic cancer cells. Cell Biosci. 2021;11(1):37. doi: 10.1186/s13578-021-00550-3.
   PubMed Web of Science ®Google Scholar
• Linares R, Tan S, Gounou C, et al. High-speed centrifugation induces aggregation of extracellular vesicles. J Extracell Vesicles. 2015;4(1):29509. doi: 10.3402/jev.v4.29509.
   Web of Science ®Google Scholar
• Lobb RJ, Becker M, Wen SW, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4(1):27031. doi: 10.3402/jev.v4.27031.
   PubMed Web of Science ®Google Scholar
• Yang J, Gao X, Xing X, et al. An isolation system to collect high quality and purity extracellular vesicles from serum. Int J Nanomedicine. 2021;16:6681–6692. doi: 10.2147/IJN.S328325.
   PubMedGoogle Scholar
• Baranyai T, Herczeg K, Onódi Z, et al. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015;10(12):e0145686. doi: 10.1371/journal.pone.0145686.
   PubMed Web of Science ®Google Scholar
• Wei R, Zhao L, Kong G, et al. Combination of size-exclusion chromatography and ultracentrifugation improves the proteomic profiling of plasma-derived small extracellular vesicles. Biol Proced Online. 2020;22(1):12. doi: 10.1186/s12575-020-00125-5.
   Web of Science ®Google Scholar
• Huang K, Garimella S, Clay-Gilmour A, et al. Comparison of human urinary exosomes isolated via ultracentrifugation alone versus ultracentrifugation followed by sec column-purification. J Pers Med. 2022;12(3):340. doi: 10.3390/jpm12030340.
   PubMed Web of Science ®Google Scholar
• Mousavi SM, Amin Mahdian SM, Ebrahimi MS, et al. Microfluidics for detection of exosomes and microRNAs in cancer: state of the art. Mol Ther Nucleic Acids. 2022;28:758–791. doi: 10.1016/j.omtn.2022.04.011.
   PubMedGoogle Scholar
• Zhang H, Freitas D, Kim HS, et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol. 2018;20(3):332–343. doi: 10.1038/s41556-018-0040-4.
   PubMed Web of Science ®Google Scholar
• Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27(5):796–810. doi: 10.1007/s11095-010-0073-2.
   PubMed Web of Science ®Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011;7(6):780–788. doi: 10.1016/j.nano.2011.04.003.
   PubMed Web of Science ®Google Scholar
• Akers JC, Ramakrishnan V, Nolan JP, et al. Comparative analysis of technologies for quantifying extracellular vesicles (EVS) in clinical cerebrospinal fluids (CSF). PLoS One. 2016;11(2):e0149866. doi: 10.1371/journal.pone.0149866.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi J, Huang J, et al. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020;15:6917–6934. doi: 10.2147/IJN.S264498.
   PubMed Web of Science ®Google Scholar
• Liu X, Zong Z, Xing M, et al. pH-mediated clustering of exosomes: breaking through the size limit of exosome analysis in conventional flow cytometry. Nano Lett. 2021;21(20):8817–8823. doi: 10.1021/acs.nanolett.1c03211.
   Web of Science ®Google Scholar
• Van Der Pol E, Coumans FA, Grootemaat AE, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182–1192. doi: 10.1111/jth.12602.
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247. doi: 10.1126/science.1153124.
   PubMed Web of Science ®Google Scholar
• Nakao Y, Amrollahi P, Parthasarathy G, et al. Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery. Nanomedicine. 2021;36:102430. doi: 10.1016/j.nano.2021.102430.
   Web of Science ®Google Scholar
• Landa S, Verlov N, Fedorova N, et al. Extracellular particles as carriers of cholesterol not associated with lipoproteins. Membranes (Basel). 2022;12(6):618. doi: 10.3390/membranes12060618.
   Web of Science ®Google Scholar
• Wang W, Zhu N, Yan T, et al. The crosstalk: exosomes and lipid metabolism. Cell Commun Signal. 2020;18(1):119. doi: 10.1186/s12964-020-00581-2.
   Web of Science ®Google Scholar
• Zhao Z, Zhong L, Li P, et al. Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal mir-122-5p. Exp Cell Res. 2020;387(1):111738. doi: 10.1016/j.yexcr.2019.111738.
   PubMed Web of Science ®Google Scholar
• Abdullah M, Nakamura T, Ferdous T, et al. Cholesterol regulates exosome release in cultured astrocytes. Front Immunol. 2021;12:722581. doi: 10.3389/fimmu.2021.722581.
   Web of Science ®Google Scholar
• Zhao Y, Zhao MF, Jiang S, et al. Liver governs adipose remodelling via extracellular vesicles in response to lipid overload. Nat Commun. 2020;11(1):719. doi: 10.1038/s41467-020-14450-6.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang T, Zhang X, et al. Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis. BMC Cardiovasc Disord. 2022;22(1):61. doi: 10.1186/s12872-022-02508-w.
   Web of Science ®Google Scholar
• Fujita K, Somiya M, Kuroda S, et al. Induction of lipid droplets in non-macrophage cells as well as macrophages by liposomes and exosomes. Biochem Biophys Res Commun. 2019;510(1):184–190. doi: 10.1016/j.bbrc.2019.01.078.
   Web of Science ®Google Scholar
• Povero D, Eguchi A, Li H, et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One. 2014;9(12):e113651. doi: 10.1371/journal.pone.0113651.
   PubMed Web of Science ®Google Scholar
• Kakazu E, Mauer AS, Yin M, et al. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an Ire1alpha-dependent manner. J Lipid Res. 2016;57(2):233–245. doi: 10.1194/jlr.M063412.
   PubMed Web of Science ®Google Scholar
• Li J, Liu H, Mauer AS, et al. Characterization of cellular sources and circulating levels of extracellular vesicles in a dietary murine model of nonalcoholic steatohepatitis. Hepatol Commun. 2019;3(9):1235–1249. doi: 10.1002/hep4.1404.
   Web of Science ®Google Scholar
• Zhang J, Tan J, Wang M, et al. Lipid-induced dram recruits stom to lysosomes and induces LMP to promote exosome release from hepatocytes in NAFLD. Sci Adv. 2021;7(45):eabh1541. doi: 10.1126/sciadv.abh1541.
   Web of Science ®Google Scholar
• Povero D, Eguchi A, Niesman IR, et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require vanin-1 for uptake by endothelial cells. Sci Signal. 2013;6(296):ra88. doi: 10.1126/scisignal.2004512.
   Web of Science ®Google Scholar
• Povero D, Yamashita H, Ren W, et al. Characterization and proteome of circulating extracellular vesicles as potential biomarkers for nash. Hepatol Commun. 2020;4(9):1263–1278. doi: 10.1002/hep4.1556.
   Web of Science ®Google Scholar
• Kornek M, Lynch M, Mehta SH, et al. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology. 2012;143(2):448–458. doi: 10.1053/j.gastro.2012.04.031.
   PubMed Web of Science ®Google Scholar
• Welsh JA, Scorletti E, Clough GF, et al. Leukocyte extracellular vesicle concentration is inversely associated with liver fibrosis severity in NAFLD. J Leukoc Biol. 2018;104(3):631–639. doi: 10.1002/JLB.5A1217-501R.
   Web of Science ®Google Scholar
• Hirsova P, Ibrahim SH, Krishnan A, et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150(4):956–967. doi: 10.1053/j.gastro.2015.12.037.
   PubMed Web of Science ®Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19–30. doi: 10.1038/ncb2000.
   PubMed Web of Science ®Google Scholar
• Liao CY, Song MJ, Gao Y, et al. Hepatocyte-derived lipotoxic extracellular vesicle sphingosine 1-phosphate induces macrophage chemotaxis. Front Immunol. 2018;9:2980. doi: 10.3389/fimmu.2018.02980.
   PubMed Web of Science ®Google Scholar
• Dasgupta D, Nakao Y, Mauer AS, et al. Ire1a stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis. Gastroenterology. 2020;159(4):1487–1503.e1417. doi: 10.1053/j.gastro.2020.06.031.
   PubMed Web of Science ®Google Scholar
• Fukushima M, Dasgupta D, Mauer AS, et al. Star-related lipid transfer domain 11 (Stard11)-mediated ceramide transport mediates extracellular vesicle biogenesis. J Biol Chem. 2018;293(39):15277–15289. doi: 10.1074/jbc.RA118.002587.
   Web of Science ®Google Scholar
• Mauer AS, Hirsova P, Maiers JL, et al. Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G300–G313. doi: 10.1152/ajpgi.00222.2016.
   Web of Science ®Google Scholar
• Zhang X, Shen J, Man K, et al. Cxcl10 plays a key role as an inflammatory mediator and a non-Invasive biomarker of non-alcoholic steatohepatitis. J Hepatol. 2014;61(6):1365–1375. doi: 10.1016/j.jhep.2014.07.006.
   Web of Science ®Google Scholar
• Ibrahim SH, Hirsova P, Tomita K, et al. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology. 2016;63(3):731–744. doi: 10.1002/hep.28252.
   Web of Science ®Google Scholar
• Tomita K, Freeman BL, Bronk SF, et al. Cxcl10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis. Sci Rep. 2016;6(1):28786. doi: 10.1038/srep28786.
   PubMedGoogle Scholar
• Tomita K, Kabashima A, Freeman BL, et al. Mixed lineage kinase 3 mediates the induction of Cxcl10 by a Stat1-dependent mechanism during hepatocyte lipotoxicity. J Cellular Biochem. 2017;118(10):3249–3259. doi: 10.1002/jcb.25973.
   PubMed Web of Science ®Google Scholar
• Ibrahim SH, Gores GJ, Hirsova P, et al. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int. 2014;34(3):427–437. doi: 10.1111/liv.12353.
   Web of Science ®Google Scholar
• Nojima H, Konishi T, Freeman CM, et al. Chemokine receptors, Cxcr1 and Cxcr2, differentially regulate exosome release in hepatocytes. PLoS One. 2016;11(8):e0161443. doi: 10.1371/journal.pone.0161443.
   Web of Science ®Google Scholar
• Dhayni K, Zibara K, Issa H, et al. Targeting Cxcr1 and Cxcr2 receptors in cardiovascular diseases. Pharmacol Ther. 2022;237:108257. doi: 10.1016/j.pharmthera.2022.108257.
   Web of Science ®Google Scholar
• Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13(26):3540–3553. doi: 10.3748/wjg.v13.i26.3540.
   Web of Science ®Google Scholar
• Duan Y, Pan X, Luo J, et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. 2022;13:880298. doi: 10.3389/fimmu.2022.880298.
   PubMed Web of Science ®Google Scholar
• Lee EY, Lee ZH, Song YW. Cxcl10 and autoimmune diseases. Autoimmun Rev. 2009;8(5):379–383. doi: 10.1016/j.autrev.2008.12.002.
   PubMed Web of Science ®Google Scholar
• Cannito S, Morello E, Bocca C, et al. Microvesicles released from fat-laden cells promote activation of hepatocellular Nlrp3 inflammasome: a pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. PLoS One. 2017;12(3):e0172575. doi: 10.1371/journal.pone.0172575.
   PubMed Web of Science ®Google Scholar
• Guo Q, Furuta K, Lucien F, et al. Integrin beta1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine nash. J Hepatol. 2019;71(6):1193–1205. doi: 10.1016/j.jhep.2019.07.019.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez I, Santoro N, Chen Y, et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of Tlr9. J Clin Invest. 2016;126(3):859–864. doi: 10.1172/JCI83885.
   PubMed Web of Science ®Google Scholar
• Hernández A, Geng Y, Sepúlveda R, et al. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with kupffer cells through extracellular vesicles. Biochim Biophys Acta Mol Basis Dis. 2020;1866(6):165753. doi: 10.1016/j.bbadis.2020.165753.
   PubMed Web of Science ®Google Scholar
• Hernández A, Reyes D, Geng Y, et al. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells. Biochim Biophys Acta Mol Basis Dis. 2020;1866(10):165857. doi: 10.1016/j.bbadis.2020.165857.
   Web of Science ®Google Scholar
• Gim JA, Bang SM, Lee YS, et al. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal mirna expression. PLoS One. 2021;16(8):e0255822. doi: 10.1371/journal.pone.0255822.
   Web of Science ®Google Scholar
• López-Pastor AR, Infante-Menéndez J, González-Illanes T, et al. Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice. Dis Model Mech. 2021;14(12):dmm049173. doi: 10.1242/dmm.049173.
   Web of Science ®Google Scholar
• Newman LA, Useckaite Z, Johnson J, et al. Selective isolation of liver-derived extracellular vesicles redefines performance of mirna biomarkers for non-alcoholic fatty liver disease. Biomedicines. 2022;10(1):195. doi: 10.3390/biomedicines10010195.
   Web of Science ®Google Scholar
• Zhang JW, Pan HT. Microrna profiles of serum exosomes derived from children with nonalcoholic fatty liver. Genes Genomics. 2022;44(7):879–888. doi: 10.1007/s13258-021-01150-8.
   PubMed Web of Science ®Google Scholar
• Jiang H, Qian Y, Shen Z, et al. Circulating microRNA135a3p in serum extracellular vesicles as a potential biological marker of nonalcoholic fatty liver disease. Mol Med Rep. 2021;24(1):498. doi: 10.3892/mmr.2021.12137.
   Google Scholar
• Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One. 2011;6(8):e23937. doi: 10.1371/journal.pone.0023937.
   PubMed Web of Science ®Google Scholar
• Pirola CJ, Gianotti TF, Castaño GO, et al. Circulating microRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndrome. Hepatology. 2013;57(6):2545–2547. doi: 10.1002/hep.26116.
   PubMed Web of Science ®Google Scholar
• Csak T, Bala S, Lippai D, et al. MicroRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int. 2015;35(2):532–541. doi: 10.1111/liv.12633.
   PubMed Web of Science ®Google Scholar
• Liu XL, Pan Q, Cao HX, et al. Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through rictor/AKT/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease. Hepatology. 2020;72(2):454–469. doi: 10.1002/hep.31050.
   PubMed Web of Science ®Google Scholar
• Liu H, Niu Q, Wang T, et al. Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages. Int J Biol Sci. 2021;17(14):3745–3759. doi: 10.7150/ijbs.57610.
   Web of Science ®Google Scholar
• Koenen MT, Brandt EF, Kaczor DM, et al. Extracellular vesicles from steatotic hepatocytes provoke pro-fibrotic responses in cultured stellate cells. Biomolecules. 2022;12(5):698. doi: 10.3390/biom12050698.
   Web of Science ®Google Scholar
• Povero D, Panera N, Eguchi A, et al. Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma. Cell Mol Gastroenterol Hepatol. 2015;1(6):646–663.e644. doi: 10.1016/j.jcmgh.2015.07.007.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim SY, Ko E, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7(1):3710. doi: 10.1038/s41598-017-03389-2.
   PubMedGoogle Scholar
• Gao H, Jin Z, Bandyopadhyay G, et al. Mir-690 treatment causes decreased fibrosis and steatosis and restores specific kupffer cell functions in nash. Cell Metab. 2022;34(7):978–990.e974. doi: 10.1016/j.cmet.2022.05.008.
   Web of Science ®Google Scholar
• Hou X, Yin S, Ren R, et al. Myeloid-cell-specific Il-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis. Hepatology. 2021;74(1):116–132. doi: 10.1002/hep.31658.
   PubMed Web of Science ®Google Scholar
• He Y, Hwang S, Cai Y, et al. MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes. Hepatology. 2019;70(4):1150–1167. doi: 10.1002/hep.30645.
   PubMed Web of Science ®Google Scholar
• He Y, Rodrigues RM, Wang X, et al. Neutrophil-to-hepatocyte communication via LDLR-dependent mir-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. J Clin Invest. 2021;131(3):e141513. doi: 10.1172/JCI141513.
   Web of Science ®Google Scholar
• Calvente CJ, Tameda M, Johnson CD, et al. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019;129(10):4091–4109. doi: 10.1172/JCI122258.
   PubMed Web of Science ®Google Scholar
• He Y, Feng D, Li M, et al. Hepatic mitochondrial DNA/toll-like receptor 9/microRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice. Hepatology. 2017;66(1):220–234. doi: 10.1002/hep.29153.
   PubMed Web of Science ®Google Scholar
• Duval C, Thissen U, Keshtkar S, et al. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57bl/6 mice. Diabetes. 2010;59(12):3181–3191. doi: 10.2337/db10-0224.
   PubMed Web of Science ®Google Scholar
• Flaherty SE, 3rd, Grijalva A, Xu X, et al. A lipase-independent pathway of lipid release and immune modulation by adipocytes. Science. 2019;363(6430):989–993. doi: 10.1126/science.aaw2586.
   PubMed Web of Science ®Google Scholar
• Castaño C, Kalko S, Novials A, et al. Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice. Proc Natl Acad Sci U S A. 2018;115(48):12158–12163. doi: 10.1073/pnas.1808855115.
   PubMed Web of Science ®Google Scholar
• Gu H, Yang K, Shen Z, et al. Er stress-induced adipocytes secrete-aldo-keto reductase 1b7-containing exosomes that cause nonalcoholic steatohepatitis in mice. Free Radic Biol Med. 2021;163:220–233. doi: 10.1016/j.freeradbiomed.2020.12.011.
   PubMed Web of Science ®Google Scholar
• Yan C, Tian X, Li J, et al. A high-fat diet attenuates AMPK Alpha1 in adipocytes to induce exosome shedding and nonalcoholic fatty liver development in vivo. Diabetes. 2021;70(2):577–588. doi: 10.2337/db20-0146.
   Web of Science ®Google Scholar
• Larter CZ, Yeh MM, Van Rooyen DM, et al. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol. 2009;24(10):1658–1668. doi: 10.1111/j.1440-1746.2009.05996.x.
   Web of Science ®Google Scholar
• Li Y, Luan Y, Li J, et al. Exosomal mir-199a-5p promotes hepatic lipid accumulation by modulating Mst1 expression and fatty acid metabolism. Hepatol Int. 2020;14(6):1057–1074. doi: 10.1007/s12072-020-10096-0.
   PubMed Web of Science ®Google Scholar
• Gu N, You L, Shi C, et al. Expression of mir-199a-3p in human adipocytes is regulated by free fatty acids and adipokines. Mol Med Rep. 2016;14(2):1180–1186. doi: 10.3892/mmr.2016.5379.
   Web of Science ®Google Scholar
• Czech MP. Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Mol Metab. 2020;34:27–42. doi: 10.1016/j.molmet.2019.12.014.
   Web of Science ®Google Scholar
• Zhang X, Ji X, Wang Q, et al. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell. 2018;9(2):164–177. doi: 10.1007/s13238-017-0436-0.
   Web of Science ®Google Scholar
• Du Plessis J, Van Pelt J, Korf H, et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology. 2015;149(3):635–648.e614. doi: 10.1053/j.gastro.2015.05.044.
   PubMed Web of Science ®Google Scholar
• Koeck ES, Iordanskaia T, Sevilla S, et al. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease. J Surg Res. 2014;192(2):268–275. doi: 10.1016/j.jss.2014.06.050.
   PubMed Web of Science ®Google Scholar
• Ferrante SC, Nadler EP, Pillai DK, et al. Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr Res. 2015;77(3):447–454. doi: 10.1038/pr.2014.202.
   PubMed Web of Science ®Google Scholar
• Zhao J, Hu L, Gui W, et al. Hepatocyte TGF-beta signaling inhibiting wat browning to promote NAFLD and obesity is associated with let-7b-5p. Hepatol Commun. 2022;6(6):1301–1321. doi: 10.1002/hep4.1892.
   Web of Science ®Google Scholar
• Shang Q, Bai Y, Wang G, et al. Delivery of adipose-derived stem cells attenuates adipose tissue inflammation and insulin resistance in obese mice through remodeling macrophage phenotypes. Stem Cells Dev. 2015;24(17):2052–2064. doi: 10.1089/scd.2014.0557.
   PubMed Web of Science ®Google Scholar
• He Q, Wang L, Zhao R, et al. Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy. Stem Cell Res Ther. 2020;11(1):223. doi: 10.1186/s13287-020-01731-6.
   PubMed Web of Science ®Google Scholar
• Hyvärinen K, Holopainen M, Skirdenko V, et al. Mesenchymal stromal cells and their extracellular vesicles enhance the anti-inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (Il)-23 and Il-22. Front Immunol. 2018;9:771. doi: 10.3389/fimmu.2018.00771.
   Web of Science ®Google Scholar
• Bruno S, Pasquino C, Herrera Sanchez MB, et al. HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis. Mol Ther. 2020;28(2):479–489. doi: 10.1016/j.ymthe.2019.10.016.
   PubMed Web of Science ®Google Scholar
• Cheng L, Yu P, Li F, et al. Human umbilical cord-derived mesenchymal stem cell-exosomal mir-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression. Hum Cell. 2021;34(6):1697–1708. doi: 10.1007/s13577-021-00593-1.
   PubMed Web of Science ®Google Scholar
• Tan Y, Huang Y, Mei R, et al. Hucmsc-derived exosomes delivered Becn1 induces ferroptosis of hepatic stellate cells via regulating the Xct/Gpx4 axis. Cell Death Dis. 2022;13(4):319. doi: 10.1038/s41419-022-04764-2.
   PubMed Web of Science ®Google Scholar
• El-Derany MO, Abdelhamid SG. Upregulation of mir-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: emphasis on caspase-2 signaling inhibition. Biochem Pharmacol. 2021;190:114624. doi: 10.1016/j.bcp.2021.114624.
   Web of Science ®Google Scholar
• Zhang Q, Liu X, Piao C, et al. Effect of conditioned medium from adipose derived mesenchymal stem cells on endoplasmic reticulum stress and lipid metabolism after hepatic ischemia reperfusion injury and hepatectomy in swine. Life Sci. 2022;289:120212. doi: 10.1016/j.lfs.2021.120212.
   Web of Science ®Google Scholar
• Shuen TWH, Alunni-Fabbroni M, Öcal E, et al. Extracellular vesicles may predict response to radioembolization and sorafenib treatment in advanced hepatocellular carcinoma: an exploratory analysis from the soramic trial. Clin Cancer Res. 2022;28(17):3890–3901. doi: 10.1158/1078-0432.Ccr-22-0569.
   Web of Science ®Google Scholar
• Zuo R, Ye LF, Huang Y, et al. Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7. J Nanobiotechnol. 2021;19(1):396. doi: 10.1186/s12951-021-01137-3.
   Web of Science ®Google Scholar
• Jiang F, Chen Q, Wang W, et al. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1. J Hepatol. 2020;72(1):156–166. doi: 10.1016/j.jhep.2019.09.014.
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe covid-19. Stem Cells Dev. 2020;29(12):747–754. doi: 10.1089/scd.2020.0080.
   PubMed Web of Science ®Google Scholar
• Fuhrmann G, Herrmann IK, Stevens MM. Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges. Nano Today. 2015;10(3):397–409. doi: 10.1016/j.nantod.2015.04.004.
   PubMed Web of Science ®Google Scholar